Ischemic Attack, Transient: Clinical Trials

3 trials for Ischemic Attack, Transient, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow Ischemic Attack, Transient: new trials by email Literature Review of Ischemic Attack, Transient trials Research Report on Ischemic Attack, Transient

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event
Vitamin E tocotrienol (TCT) capsules ; Low dose Aspirin, Placebo vehicle control - Ischemic Stroke, Transient Ischemic Attack (TIA)
Phase 1 / Phase 2CompletedAndrew Slivka2102012-03-012021-09-20
Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy
Pharmacogenomics testing for clopidogrel responsiveness - Stroke, Transient Ischemic Attack
Phase 1CompletedUniversity of North Carolina, Chapel Hill482011-12-012012-06-08
Improved Delivery of Cardiovascular Care Through Outreach Facilitation
Outreach Facilitation implementing elements of the Chronic Care Model - Hypertension, Dyslipidemia
Phase 1CompletedC. T. Lamont Primary Care Research Centre1942007-04-012014-10-06

Narrower conditions

Stroke (3)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Dyslipidemias (1)  ·  Hypertension (1)  ·  Ischemia (1)  ·  Ischemic Stroke (1)  ·  Myocardial Infarction (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Brain Diseases (3)  ·  Brain Ischemia (3)  ·  Central Nervous System Diseases (3)  ·  Cerebrovascular Disorders (3)  ·  Nervous System Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  Cardiovascular Diseases (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glucose Metabolism Disorders (1)

Interventions

Aspirin (1)  ·  Capsules (1)  ·  Pharmacogenomic Testing (1)  ·  Precision Medicine (1)  ·  Thrombin Time (1)

Sponsors

Andrew Slivka (1)  ·  C. T. Lamont Primary Care Research Centre (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Clare E Liddy, MD, MSc (1)  ·  Stefanie Ferreri, PharmD (1)  ·  William Hogg, MD, MSc (1)

Results publications

PMID 21952084, PMID 22008366, PMID 22970753, PMID 26510577, PMID 27596224, PMID 28271017